Latest filing published 07 Jun 2024 for Allovir, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Juan Vera: trading record in brief
Filings by Juan Vera span 2 companies, the busiest being Kalaris Therapeutics, Inc. and Marker Therapeutics, Inc. Between 3 August 2020 and 6 June 2024, the trades on record add up to 31 filings.
The open-market side counts 1 purchase for €839k alongside 25 sales for €4.2M. Netting one side against the other leaves €3.3M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 4 share grants.
The latest filing, published on 7 June 2024, reports a share grant in Kalaris Therapeutics, Inc. The last insider purchase was made public on 18 March 2021, 2,061 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Juan Vera
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 35,000 shares0Common StockSEC:0000950170-24-070597:0
- 35,000 shares0Common StockSEC:0001209191-23-029099:0
- 140,823 shares0Common StockSEC:0001209191-22-021395:0
3 of 3 declarations
